LGALS3 and neoplasm: In parallel, Gal-3 promotes the expansion of myeloid-derived suppressor cells (MDSCs) and M2-polarized macrophages, contributing to an immune-suppressive TME that supports tumor growth and resistance to immunotherapy [12].